A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD
Clinical trial NCT03841773 · TERMINATED
Trial details
- NCT number
- NCT03841773
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2020-04-24
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.